Recently, Li et al. (2020) revealed that patients with PD with EPVS in the substantia nigra (SN) showed greater expression of tau protein in CSF and a trend toward reduced DAT binding than those without SN-EPVS. Here, SLC6A3 is linked to Parkinson disease.